Maryland legislation · 2026 Regular Session
Maryland SB78: Public Health – Prostate–Specific Antigen Testing (Protect Our Prostate Act)
Status: In committee, January 21, 2026
Requiring certain providers and laboratories to provide certain written information to patients receiving prostate-specific antigen testing; and requiring clinical laboratories that administer prostate-specific antigen tests to follow certain disclosure requirements, use standard calibration for testing assays and report test results in a standard manner, make certain disclosures to ordering providers, and follow guidelines from certain organizations.
What the bill says
A bill ENTITLED AN ACT concerning Public Health - Prostate-Specific Antigen Testing (Protect Our Prostate Act) FOR the purpose of requiring certain providers and laboratories to provide certain written information to patients receiving prostate-specific antigen testing; requiring clinical laboratories that administer prostate-specific antigen tests to follow certain disclosure requirements, use standard calibration for testing assays and report test results in a standard manner, make certain disclosures to ordering providers, and follow guidelines from certain organizations…
From the introduced text, January 10, 2026:
A BILL ENTITLED AN ACT concerning Public Health - Prostate-Specific Antigen Testing (Protect Our Prostate Act) FOR the purpose of requiring certain providers and laboratories to provide certain written information to patients receiving prostate-specific antigen testing; requiring clinical laboratories that administer prostate-specific antigen tests to follow certain disclosure requirements, use standard calibration for testing assays and report test results in a standard manner, make certain disclosures to ordering providers, and follow guidelines from certain organizations; and generally relating to prostate-specific antigen testing. BY adding to Article - Health - General Section 17-801 through 17-803 to be under the new subtitle "Subtitle 8. Prostate-Specific Antigen Testing" Annotated Code of Maryland (2023 Replacement Volume and 2025 Supplement) Preamble WHEREAS, Prostate-specific antigen testing, while an important tool for the early detection of prostate cancer, is not a definitive diagnostic tool and can produce misleading results that could lead to invasive biopsies or overtreatment; and WHEREAS, Patients undergoing prostate-specific antigen testing should be adequately informed of the potential costs associated with the testing and the implications surrounding false-positive results; now, therefore, SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, That the Laws of Maryland read as follows: EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW. [Brackets] indicate matter deleted from exist in g l aw . *sb0078* SENATE BILL Article - …